Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
Isolab, Inc. — Predicate Candidate Screening
44 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
92 daysmedian FDA review time
277 days90th percentile
44clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K951014 | ISOLAB'S T4 TEST KIT | Isolab, Inc. | 1996-10-18 | 592 | 0 |
| K950481 | NEONATAL CHEMISTRY SYSTEM, GALACTOSE TEST KIT | Isolab, Inc. | 1996-02-01 | 363 | 5 |
| K943547 | PHENYLALANINE TEST KIT | Isolab, Inc. | 1996-01-26 | 554 | 0 |
| K950803 | ISOLAB'S GALACTOSE-1-PHOSPHATE URIDYL TRANFERASE TEST KITS 8 | Isolab, Inc. | 1995-09-21 | 212 | 2 |
| K950415 | FLUOROSCAN NEONATAL | Isolab, Inc. | 1995-09-05 | 217 | 0 |
| K942222 | QUIK-SEP QUANTITIVE HEMOGLOBIN S CONTROLS | Isolab, Inc. | 1995-01-20 | 259 | 0 |
| K942276 | QUIK-SEP QUANTITATIVE HEMOGLOBIN S ASSAY | Isolab, Inc. | 1995-01-20 | 255 | 0 |
| K944185 | ISOSCAN | Isolab, Inc. | 1994-11-17 | 83 | 0 |
| K934013 | RESOLVE SYSTEMS ALKALINE PHOSPHATASE TEST KIT | Isolab, Inc. | 1994-04-26 | 251 | 0 |
| K923153 | HEMOCARD, HEMOGLOBIN C ASSAY | Isolab, Inc. | 1994-01-27 | 577 | 0 |
| K931234 | HEMOCARD CONTROL HB-AA, AE, FAA, FAE | Isolab, Inc. | 1993-05-11 | 62 | 0 |
| K930070 | HEMOCARD HEMOGLOBIN E | Isolab, Inc. | 1993-04-08 | 92 | 0 |
| K924173 | HEMOCARD(TM) CONTROL | Isolab, Inc. | 1992-12-01 | 104 | 0 |
| K921681 | CRITERION, HEMOCUE B-HEMOGLOBIN CONTROL | Isolab, Inc. | 1992-11-17 | 223 | 0 |
| K911981 | HEMOCARD HEMOGLOBIN S | Isolab, Inc. | 1991-10-09 | 159 | 0 |
| K910430 | HEMOCARD-AS | Isolab, Inc. | 1991-04-15 | 73 | 0 |
| K910431 | HEMOCARD CONTROL | Isolab, Inc. | 1991-03-11 | 38 | 0 |
| K905513 | GLYC-AFFIN(TM)-GA | Isolab, Inc. | 1991-01-15 | 36 | 0 |
| K904814 | GLYC-AFFIN GP | Isolab, Inc. | 1990-12-26 | 63 | 0 |
| K902740 | LDL-DIRECT CONTROLS | Isolab, Inc. | 1990-12-07 | 168 | 0 |
| K901453 | QUIK-SEP(R) IGM RPROTEIN G AFFINITY METHOD | Isolab, Inc. | 1990-04-12 | 16 | 0 |
| K883411 | PG-NUMERIC(TM) | Isolab, Inc. | 1989-03-15 | 212 | 0 |
| K880673 | GHB SAMPLE PAPER | Isolab, Inc. | 1988-11-22 | 277 | 0 |
| K873428 | GLYCO-PROBE GSP | Isolab, Inc. | 1988-04-05 | 224 | 0 |
| K862638 | VISIBLE-CHLAMYDIA(TM) TEST SYSTEM | Isolab, Inc. | 1986-08-26 | 47 | 0 |
| K854712 | VISIBLE-HERPES TM TEST SYSTEM | Isolab, Inc. | 1986-05-20 | 179 | 0 |
| K843122 | RESOLVE-CSF | Isolab, Inc. | 1984-11-30 | 114 | 1 |
| K842152 | SICKLING HEMOGLOBIN CONTROLS, NORMAL | Isolab, Inc. | 1984-09-09 | 102 | 0 |
| K841170 | SICKLE HB ASSAY | Isolab, Inc. | 1984-04-04 | 16 | 0 |
| K840011 | RESOLVE-HB | Isolab, Inc. | 1984-02-04 | 31 | 2 |
| K830606 | QUIK-SEP IGM ISOLATION SYSTEM | Isolab, Inc. | 1983-03-24 | 27 | 0 |
| K822867 | GLYC-AFFIN GLYCOHEMOGLOBIN ASSAY | Isolab, Inc. | 1982-12-03 | 67 | 0 |
| K820630 | QUIK-SEP HEMOGLOBIN F ASSAY & CONTROL | Isolab, Inc. | 1982-06-25 | 109 | 0 |
| K812318 | LIPO-SEP CHOLESTEROL AUDIT SYSTEM | Isolab, Inc. | 1981-09-01 | 15 | 0 |
| K810976 | ALPHA-THAL SCREEN TM CONTROL | Isolab, Inc. | 1981-05-29 | 49 | 0 |
| K810919 | HEMOGLOBIN ELECTROPHORESIS CONTROL | Isolab, Inc. | 1981-04-23 | 17 | 0 |
| K801771 | ALPHA-THAL SCREEN 20 TEST KIT & 100 KIT | Isolab, Inc. | 1981-01-16 | 172 | 0 |
| K802997 | HDL-CHOLESTEROL CONTROL SERUM | Isolab, Inc. | 1980-12-22 | 27 | 0 |
| K801410 | HEMOHLOBIN A2 CONTROL-LYOPHILIZED | Isolab, Inc. | 1980-07-21 | 35 | 0 |
| K800794 | FAST HEMOGLOBIN CONTROL-LYOPHILIZED | Isolab, Inc. | 1980-04-29 | 20 | 0 |
| K791143 | SICKLE-CELL F TEST | Isolab, Inc. | 1979-07-17 | 29 | 0 |
| K781851 | HEMOGLOBIN, TESTING SYSTEM | Isolab, Inc. | 1978-11-07 | 4 | 0 |
| K780998 | SCALPEL | Isolab, Inc. | 1978-07-27 | 43 | 0 |
| K771649 | HEMOGLOBIN A2 TESTING SYSTEM | Isolab, Inc. | 1977-10-07 | 39 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda